• Devised a portfolio strategy for a global pharmaceutical company targeting EMEA and Indian markets• Formulated a model outlining potential healthcare reform evolution scenarios in a CIS country• Successfully conducted commercial due diligence for a $90M hospital in Ukraine

• Formulated the fund's portfolio strategy• Led an analytical team in top-down structuring of shareholders’ objectives, daily plan monitoring, presenting deliverables to shareholders, and executing due diligence & valuation• Conducted >20 negotiations with target executives (CFO, CEO, shareholders) to structure ~$25M deals• Collaboratively developed several JV scenarios for localizing global pharmaceutical companies in a CIS country through fund investment

Developed a 10-year growth strategy for a top 3 global pharma firm to pinpoint target product portfolio structure:• Evaluated the impact of government initiatives in 4 peer nations to forge a scenario model of regulation landscape & project sales • Conceived a series of localization strategies to bolster the company's regional footprint, encompassing M&A, manufacturing localization, and potential R&D partnership

Completed Research project, during which I applied the genetic engineering technics, cloned DNA and created the RNAi construct which allowed down-regulation of the target gene

• Contributed development of the biopharmaceutical sub-fund ($200M) portfolio strategy• Accomplished financial and technological DD of a target biopharmaceutical company ($100M pre-money valuation)

Prepared an overview of the competitive landscape and deals in the cancer vaccine market, furnishing the company with insights into potential strategic M&A exit scenarios. Participated in fundraising activities, culminating in a $5M capital investment

Assisted in ~20 operations (e.g. colectomy) in the abdominal surgery and critical care departments